Filing Details

Accession Number:
0000899243-21-024427
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-17 16:33:25
Reporting Period:
2021-06-16
Accepted Time:
2021-06-17 16:33:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651431 Checkmate Pharmaceuticals Inc. CMPI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1335659 M Arthur Krieg C/O Checkmate Pharmaceuticals, Inc.
245 Main Street, 2Nd Floor
Cambridge MA 02142
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-16 3,578 $6.18 808,510 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions, at prices ranging from $6.17 to $6.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.